Real-world Evidence for Label Expansion

 

This video talks about FDA's growing acceptance of the use of real-world data to generate real-world evidence in support of regulatory submissions for pharmaceutical products and medical devices. Dr. Won Chan Lee and Dr. Jennifer Ken-Opurum of Axtria talk about instances where the FDA has approved drugs based on retrospective studies. Watch the video to know more.

 

 

Similar Videos

Jassi Chadha's Spotlight Interview at Reuters Events: Pharma 2022 (Nice, France)
Learn more
Axtria US Annual Party 2021
Learn more
AxtriaTM recognized for High-Trust, High-Performance CultureTM by Great Place to Work® Institute
Learn more